Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US81663L2007
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00XDHY5P9
WGS
GeneDx Holdings Corp
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $GRLZ
NAME
GeneDx Holdings Corp
ISIN
US81663L2007
TICKER
WGS
MIC
XNAS
REUTERS
WGS.OQ
BLOOMBERG
WGS US
Fri, 19.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 19, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.06.2026       GeneDx
US81663L2007

San Diego, California--(Newsfile Corp. - June 19, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class actio...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.06.2026       GeneDx
US81663L2007

Did you buy WGS securities between April 16, 2025, and May 4, 2026?Affected WGS Investor SummaryWho: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass Period: April 16, 2025 through May 4, 2026Deadline to Seek Lead Plaintiff Status: August 3, 2026Key Lawsuit Allegations: Material misstatements and/or omissio...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.06.2026       GeneDx
US81663L2007

SAN FRANCISCO, June 19, 2026 /PRNewswire/ -- GeneDx Holdings (NASDAQ: WGS) faces a securities class action after the price of the company's stock cratered $33.42 (-49%) on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report. The lawsuit seeks to represent investors who purchased shares of GeneDx common stock between April 1...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 19.06.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wil...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 18, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 18, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.06.2026       GeneDx
US81663L2007

Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the GeneDx Holdings Corp. Securities Class Action Where Investors Lost $33.42 Per ShareNEW YORK, June 18, 2026 /PRNewswire/ -- IMPORTANT DATE: August 3, 2026. Investors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026 and wi...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 18.06.2026       GeneDx
US81663L2007

NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are e...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.06.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 18.06.2026       GeneDx
US81663L2007

NEW YORK, June 17, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A cl...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.06.2026       GeneDx
US81663L2007

Important Information Regarding Section 20(a) Individual Liability Claims Against GeneDx CEO and CFO for Alleged $33.42 Per-Share Investor Losses Tied to reimbursement weakness and underperformance of Fabric GenomicsNEW YORK, June 17, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that two se...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.06.2026       GeneDx
US81663L2007

SAN FRANCISCO, June 16, 2026 /PRNewswire/ -- GeneDx Holdings (NASDAQ: WGS) faces a securities class action after the price of the company's stock cratered $33.42 (-49%) on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report. The lawsuit seeks to represent investors who purchased shares of GeneDx common stock between April 1...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 16, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.06.2026       GeneDx
US81663L2007

NEW YORK, June 16, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GeneDx Holdings Corp. (NASDAQ: WGS). Shareholders who purchased shares of WGS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 16.06.2026       GeneDx
US81663L2007

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced the appointment of Mark Gardner as President, effective June 15, 2026.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260616791724/en/Mark Gardner joins GeneD...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 16.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 3, 2026 lead plaintiff deadline.SO WHAT: If you purchased GeneDx comm...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 15, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 15, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.06.2026       GeneDx
US81663L2007

SAN DIEGO, June 15, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit.  Captioned...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Mon, 15.06.2026       GeneDx
US81663L2007

LOS ANGELES, June 15, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U....
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 14.06.2026       GeneDx
US81663L2007

Did you buy WGS securities between April 16, 2025, and May 4, 2026?Affected WGS Investor SummaryWho: GeneDx Holdings Corp. (NASDAQ: WGS)What: Securities fraud class action lawsuit filedClass Period: April 16, 2025 through May 4, 2026Deadline to Seek Lead Plaintiff Status: August 3, 2026Key Lawsuit Allegations: Material misstatements and/or omissio...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 14.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you w...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 14.06.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sun, 14.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you w...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 13.06.2026       GeneDx
US81663L2007

San Diego, California--(Newsfile Corp. - June 12, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period"), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action law...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 13.06.2026       GeneDx
US81663L2007

NEW ORLEANS, June 12, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS), if they purchased or otherwise acquired the Company's shares between April 16,...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 13.06.2026       GeneDx
US81663L2007

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased or acquired WGS common stock between April 16, 2025, and May 4, 2026, inclusive...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Sat, 13.06.2026       GeneDx
US81663L2007

NEW YORK, June 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A cl...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 12.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 12, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 12.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you w...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Fri, 12.06.2026       GeneDx
US81663L2007

NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are e...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wils...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 11, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. ("GeneDx" or "the Company") (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U....
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 11, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged violations...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

SAN FRANCISCO, June 11, 2026 /PRNewswire/ -- GeneDx Holdings (NASDAQ: WGS) faces a securities class action after the price of the company's stock cratered $33.42 (-49%) on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report. The lawsuit seeks to represent investors who purchased shares of GeneDx common stock between April 1...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

Key Dates and Disclosure Events GeneDx Shareholders Need to Know: From $51 Million Acquisition Promise to $31.2 Million Write-Off in Just 12 MonthsNEW YORK, June 11, 2026 /PRNewswire/ -- April 16, 2025. May 5, 2025. July 29, 2025. October 28, 2025. February 23, 2026. May 4, 2026. Between these dates, GeneDx Holdings Corp. (NASDAQ: WGS) shareholder...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, both dates inclusive (the “Class Period”), have until August 3, 2026 to seek appointment as lead plaintiff of the GeneDx class action lawsuit. Captioned Basma v. GeneDx Holdings...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you w...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 10.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 10, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit agains...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 10.06.2026       GeneDx
US81663L2007

Time-Sensitive: Allegations Focus on Deteriorating Reimbursement Rates and Margin Compression Concealed From GeneDx InvestorsNEW YORK, June 10, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) of a pending securities class action. Class Period: April 16, 2025 through May 4, 2026. Check if you c...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 10.06.2026       GeneDx
US81663L2007

Philadelphia, Pennsylvania--(Newsfile Corp. - June 10, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.If you purchased GeneDx Holdings Corp....
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Wed, 10.06.2026       GeneDx
US81663L2007

New York, New York--(Newsfile Corp. - June 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wi...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 09.06.2026       GeneDx
US81663L2007

Levi & Korsinsky, LLP highlights the contrast between GeneDx Holdings Corp.'s (NASDAQ: WGS) promises to investors and the actual results of its Fabric Genomics acquisition. Shareholders who purchased WGS securities between April 16, 2025 and May 4, 2026 and suffered losses may be entitled to compensation. Find out if you can recover your invest...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink
Tue, 09.06.2026       GeneDx
US81663L2007

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 9, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against...
Read more
GeneDx
Technical Analysis Termsheets Terminal
Permalink